Gu, Y., Zhang, M., Peng, F., Fang, L., Zhang, Y., Liang, H., . . . Guo, Z. (2014). The BRCA1/2-directed miRNA signature predicts a good prognosis in ovarian cancer patients with wild-type BRCA1/2. Oncotarget.
Chicago-stil citatGu, Yunyan, Mengmeng Zhang, Fuduan Peng, Lei Fang, Yuanyuan Zhang, Haihai Liang, Wenbin Zhou, Lu Ao, och Zheng Guo. "The BRCA1/2-directed MiRNA Signature Predicts a Good Prognosis in Ovarian Cancer Patients With Wild-type BRCA1/2." Oncotarget 2014.
MLA-referensGu, Yunyan, et al. "The BRCA1/2-directed MiRNA Signature Predicts a Good Prognosis in Ovarian Cancer Patients With Wild-type BRCA1/2." Oncotarget 2014.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.